Effective Weight Loss for Children: A Meta-analysis of Intervention Studies 2002-2015

Julia A Snethen1, Marion E Broome2, Pamela Treisman3

  • 1Associate Professor, University of Wisconsin-Milwaukee, College of Nursing, Milwaukee, WI, USA.

Insights

Childhood overweight and obesity interventions show significant positive effects on weight loss. Further research should explore the role of nurses in implementing effective strategies for broader populations.

Area of Science:

  • Pediatric Health
  • Obesity Research
  • Intervention Science

Background:

  • Childhood overweight and obesity remain prevalent despite various management strategies.
  • Previous interventions have yielded limited success in curbing the rising rates.
  • A comprehensive review of existing interventions is crucial.

Purpose of the Study:

  • To evaluate the effectiveness of interventions targeting weight loss in overweight children.
  • To analyze data from studies conducted between 2002 and September 2015.
  • To synthesize findings from a meta-analysis of childhood obesity interventions.

Main Methods:

  • Systematic review and meta-analysis of 16 intervention studies.
  • Inclusion of studies focused on overweight children aged 6-15 years.
  • Interventions included dietary, physical activity, and lifestyle changes; control groups received standard care.

Main Results:

  • The meta-analysis included 19 outcomes from 2,317 participants.
  • Interventions demonstrated a significant positive effect on weight loss (g = 0.732, p < .001).
  • Most studies were conducted internationally and by interdisciplinary teams lacking nurse involvement.

Conclusions:

  • Diverse interventions significantly promote weight loss in overweight children.
  • The role of nurses in developing and implementing effective interventions needs further investigation.
  • Scaling up successful interventions is essential for broader public health impact.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
315
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
334
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
368
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
713
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
520